Inquiry Basket
2'-Modified Nucleosides
(288/288) 3'-Modified Nucleosides
(157/157) 5'-Modified Nucleosides
(236/236) Anhydro-Nucleosides
(13/13) Arabinonucleosides
(34/34) Base Protected Nucleosides
(224/224) Halogen Nucleosides
(134/134) L-Nucleosides
(18/18) Other Nucleosides
(77/77) Other Protected Nucleosides
(23/23) Ribonucleosides
(11/11)
(288/288) 3'-Modified Nucleosides
(157/157) 5'-Modified Nucleosides
(236/236) Anhydro-Nucleosides
(13/13) Arabinonucleosides
(34/34) Base Protected Nucleosides
(224/224) Halogen Nucleosides
(134/134) L-Nucleosides
(18/18) Other Nucleosides
(77/77) Other Protected Nucleosides
(23/23) Ribonucleosides
(11/11)
Backbone
Modification
Base Type
Filtered by
Clear All
9-Ribofuranosyl-9H-Purine-6-thiol
Description: 9-Ribofuranosyl-9H-Purine-6-thiol, utilized as an antiviral therapy to hinder viral replication, has been demonstrated to treat viral infections including, but not limited to, Hepatitis B and HIV. Its selectivity enables the targeted impact on infected CD4 T-helper cells, subsequently leading to a decrease of the viral load while simultaneously heightening the CD4 cell count.
CAT: BRP-01867
CAS: 4988-64-1
MF: C10H12N4O4S
MF: 284.29
Purity: ≥97% by HPLC
Appearance: Solid
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | -- | -- |
Density: 2.02±0.1 g/cm3
Boiling Point: 714.7±70.0°C at 760 mmHg
InChIKey: NKGPJODWTZCHGF-VTHZCTBJSA-N
CanonicalSMILES: C1=NC(=S)C2=C(N1)N(C=N2)C3C(C(C(O3)CO)O)O
IUPAC Name: 9-[(3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-purine-6-thione
InChI: InChI=1S/C10H12N4O4S/c15-1-4-6(16)7(17)10(18-4)14-3-13-5-8(14)11-2-12-9(5)19/h2-4,6-7,10,15-17H,1H2,(H,11,12,19)/t4-,6-,7-,10?/m1/s1
Synonyms: 9H-Purine-6-thiol, 9-ribofuranosyl-; 6H-Purine-6-thione, 3,9-dihydro-9-D-ribofuranosyl-; 6-Mercapto-9β-D-ribofuranosyl-9H-purine; 9-(D-Ribofuranosyl)-3,9-dihydro-6H-purine-6-thione; 9-(D-ribofuranosyl)-9H-purine-6-thiol
Related CAS: 574-25-4 (β-D-configuration)
Uridine 5'-(2-Methylpropanoate)
Description: An impurity of Molnupiravir which is an antiviral drug with promising activity against the SARS-CoV-2 virus.
CAT: BRP-01888
CAS: 886538-48-3
MF: C13H18N2O7
MF: 314.29
Purity: ≥98%
Appearance: White solid
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | -- | -- |
Storage: Store at 2-8 °C
Density: 1.440±0.06 g/cm3
InChIKey: XVKGAWPWDOKILJ-QCNRFFRDSA-N
CanonicalSMILES: CC(C)C(=O)OCC1C(C(C(O1)N2C=CC(=O)NC2=O)O)O
IUPAC Name: [(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl 2-methylpropanoate
InChI: InChI=1S/C13H18N2O7/c1-6(2)12(19)21-5-7-9(17)10(18)11(22-7)15-4-3-8(16)14-13(15)20/h3-4,6-7,9-11,17-18H,5H2,1-2H3,(H,14,16,20)/t7-,9-,10-,11-/m1/s1
Synonyms: Molnupiravir Impurity C; Molnupiravir Impurity 7; ((2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl isobutyrate
3'-O-Methyl-5-methyluridine
Description: 3'-O-Methyl-5-methyluridine, an essential component in the realm of nucleoside investigation, is a remarkably intricate biomedical product. Pivotal to the scientific and healing domains, it finds extensive application in the fabrication of manipulated RNA entities.
CAT: BRP-01889
CAS: 2305415-87-4
MF: C11H16N2O6
MF: 272.25
Purity: ≥95%
Appearance: White solid
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | -- | -- |
Storage: Store at 2-8 °C
Density: 1.47±0.1 g/cm3
InChIKey: YAKSSRAOGINRKE-FDDDBJFASA-N
CanonicalSMILES: CC1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)OC)O
IUPAC Name: 1-[(2R,3R,4S,5R)-3-hydroxy-5-(hydroxymethyl)-4-methoxyoxolan-2-yl]-5-methylpyrimidine-2,4-dione
InChI: InChI=1S/C11H16N2O6/c1-5-3-13(11(17)12-9(5)16)10-7(15)8(18-2)6(4-14)19-10/h3,6-8,10,14-15H,4H2,1-2H3,(H,12,16,17)/t6-,7-,8-,10-/m1/s1
Synonyms: 3'-OMe-5-Methyl-U; 1-((2R,3R,4S,5R)-3-hydroxy-5-(hydroxymethyl)-4-methoxytetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione
2',3'-O-Isopropylideneuridine
Description: A useful precursor for the preparation of nucleic acids.
CAT: BRP-01896
CAS: 362-43-6
MF: C12H16N2O6
MF: 284.27
Purity: 98%
Appearance: White to Off-White Solid
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | -- | -- |
Storage: Store at -20 °C
Density: 1.376±0.06 g/cm3
Melting Point: 160-165°C
Boiling Point: 426.76 °C at 760 mmHg
Application: A useful precursor for the preparation of nucleic acids.
InChIKey: GFDUSNQQMOENLR-PEBGCTIMSA-N
Solubility: Soluble in Chloroform (Slightly, Heated), DMSO (Slightly), Methanol (Slightly)
CanonicalSMILES: CC1(OC2C(OC(C2O1)N3C=CC(=O)NC3=O)CO)C
IUPAC Name: 1-[(3aR,4R,6R,6aR)-6-(hydroxymethyl)-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-4-yl]pyrimidine-2,4-dione
InChI: InChI=1S/C12H16N2O6/c1-12(2)19-8-6(5-15)18-10(9(8)20-12)14-4-3-7(16)13-11(14)17/h3-4,6,8-10,15H,5H2,1-2H3,(H,13,16,17)/t6-,8-,9-,10-/m1/s1
Synonyms: 1-((3AR,4R,6R,6aR)-6-(hydroxymethyl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)pyrimidine-2,4(1H,3H)-dione; Uridine 2',3'-isopropylidine; Uridine 2',3'-acetonide; Uridine, 2',3'-O-(1-methylethylidene)-; Uridine, 2',3'-O-isopropylidene-; 2',3'-Isopropylideneuridine; 2',3'-O-(1-Methylethylidene)uridine; NSC 520038
5'-O-DMT-adenosine
Description: 5'-O-DMT-adenosine is a key building block in oligonucleotide synthesis, where the 5' hydroxyl group of adenosine is protected with a DMT group. This modification allows for controlled synthesis of oligonucleotides and finds extensive use in molecular biology research and biotechnology applications.
CAT: BRP-01897
CAS: 81352-25-2
MF: C31H31N5O6
MF: 569.61
Purity: ≥95% by HPLC
Appearance: White Solid
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | -- | -- |
Storage: Store at 2-8°C
Density: 1.4±0.1 g/cm3
Melting Point: 145-147 °C
Boiling Point: 812.0±75.0°C at 760 mmHg
InChIKey: KOQFCLKBHJBRTB-BQOYKFDPSA-N
CanonicalSMILES: COC1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=C(C=C3)OC)OCC4C(C(C(O4)N5C=NC6=C(N=CN=C65)N)O)O
IUPAC Name: (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]oxolane-3,4-diol
InChI: InChI=1S/C31H31N5O6/c1-39-22-12-8-20(9-13-22)31(19-6-4-3-5-7-19,21-10-14-23(40-2)15-11-21)41-16-24-26(37)27(38)30(42-24)36-18-35-25-28(32)33-17-34-29(25)36/h3-15,17-18,24,26-27,30,37-38H,16H2,1-2H3,(H2,32,33,34)/t24-,26-,27-,30-/m1/s1
Synonyms: 5'-O-DMT adenosine; 5'-O-(4,4'-Dimethoxytrityl)adenosine; 5'-O-[Bis(4-methoxyphenyl)phenylmethyl]-adenosine; (2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)tetrahydrofuran-3,4-diol; 5-O-Dimethoxytrityladenosine
2-Chloro-N6-cyclopentyladenosine
Description: It is a selective adenosine receptor agonist and inhibits angiotensin II-induced cardiomyocyte hypertrophy through the calcineurin signaling pathway.
CAT: BRP-01900
CAS: 37739-05-2
MF: C15H20ClN5O4
MF: 369.80
Purity: ≥95% by HPLC
Appearance: Off-white to Light Yellow Solid
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | -- | -- |
Storage: Store at 2-8 °C, protect from light
Density: 1.87±0.1 g/cm3 (Predicted)
Boiling Point: 656.1±65.0 °C at 760 mmHg
InChIKey: XSMYYYQVWPZWIZ-IDTAVKCVSA-N
Solubility: Soluble in DMSO, Water
CanonicalSMILES: C1CCC(C1)NC2=C3C(=NC(=N2)Cl)N(C=N3)C4C(C(C(O4)CO)O)O
IUPAC Name: (2R,3R,4S,5R)-2-[2-chloro-6-(cyclopentylamino)purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
InChI: InChI=1S/C15H20ClN5O4/c16-15-19-12(18-7-3-1-2-4-7)9-13(20-15)21(6-17-9)14-11(24)10(23)8(5-22)25-14/h6-8,10-11,14,22-24H,1-5H2,(H,18,19,20)/t8-,10-,11-,14-/m1/s1
Synonyms: CCPA; 2-Chloro-N-cyclopentyl-adenosine; (2R,3R,4S,5R)-2-(2-chloro-6-(cyclopentylamino)-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; 2-chloro-N-cyclopentyl-9-pentofuranosyl-9H-purin-6-amine
2-Chloro-N-[(3-iodophenyl)methyl]-2',3'-O-(1-methylethylidene) Adenosine
Description: 2-Chloro-N-[(3-iodophenyl)methyl]-2',3'-O-(1-methylethylidene) Adenosine, a potent inhibitor of adenosine deaminase, exhibits anti-inflammatory and antitumor activity. Its use in research probes underexplored mechanisms that underlie various clinical conditions, and its therapeutic prospects extend to treating autoimmune disorders and cancers.
CAT: BRP-01902
CAS: 1000980-71-1
MF: C20H21ClIN5O4
MF: 557.77
Purity: 95%
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | -- | -- |
Density: 1.93±0.1 g/cm3
Boiling Point: 642.5±65.0 °C at 760 mmHg
InChIKey: WCKHUABYZBGHID-SCFUHWHPSA-N
CanonicalSMILES: CC1(OC2C(OC(C2O1)N3C=NC4=C(N=C(N=C43)Cl)NCC5=CC(=CC=C5)I)CO)C
IUPAC Name: [(3aR,4R,6R,6aR)-4-[2-chloro-6-[(3-iodophenyl)methylamino]purin-9-yl]-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]methanol
InChI: InChI=1S/C20H21ClIN5O4/c1-20(2)30-14-12(8-28)29-18(15(14)31-20)27-9-24-13-16(25-19(21)26-17(13)27)23-7-10-4-3-5-11(22)6-10/h3-6,9,12,14-15,18,28H,7-8H2,1-2H3,(H,23,25,26)/t12-,14-,15-,18-/m1/s1
Synonyms: Adenosine, 2-chloro-N-[(3-iodophenyl)methyl]-2',3'-O-(1-methylethylidene)-; [(3aR,4R,6R,6aR)-6-(2-chloro-6-{[(3-iodophenyl)methyl]amino}-9H-purin-9-yl)-2,2-dimethyl-tetrahydro-2H-furo[3,4-d][1,3]dioxol-4-yl]methanol
Guanosine-5'-carboxylic acid
Description: Guanosine-5'-carboxylic acid, a pivotal component in the realm of biomedicine, holds immense importance. Its primary role revolves around the exploration and innovation of antiviral pharmaceuticals, with a specific focus on tackling herpes simplex and varicella-zoster viruses. By serving as a fundamental cornerstone for the synthesis of robust antiviral agents, this compound actively drives significant progress in the treatment landscape of viral ailments.
CAT: BRP-01903
CAS: 15596-14-2
MF: C10H11N5O6
MF: 297.22
Purity: ≥95%
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | -- | -- |
Density: 2.42±0.1 g/cm3
InChIKey: ASAADZNSXOCOCZ-MXSWDONDSA-N
CanonicalSMILES: C1=NC2=C(N1C3C(C(C(O3)C(=O)O)O)O)N=C(NC2=O)N
IUPAC Name: (2S,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolane-2-carboxylic acid
InChI: InChI=1S/C10H11N5O6/c11-10-13-6-2(7(18)14-10)12-1-15(6)8-4(17)3(16)5(21-8)9(19)20/h1,3-5,8,16-17H,(H,19,20)(H3,11,13,14,18)/t3-,4+,5-,8+/m0/s1
Synonyms: 1-(2-Amino-1,6-dihydro-6-oxo-9H-purin-9-yl)-1-deoxy-b-D-ribofuranuronic acid; (2S,3S,4R,5R)-5-(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)-3,4-dihydroxytetrahydro-2-furancarboxylic acid; 5'-Guanylsaeure; 1-(2-amino-6-oxo-1,6-dihydro-purin-9-yl)-β-D-1-deoxy-ribofuranuronic acid
Xanthosine
Description: The deamination product of Guanosine. Potential biomarker for detecting radiation exposure. Used in the amplification of DNA isothermal strand displacement.
CAT: BRP-01904
CAS: 146-80-5
MF: C10H12N4O6
MF: 284.23
Purity: >98.0%
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | -- | -- |
Storage: Store at -20°C
Density: 2.25±0.1 g/cm3
Melting Point: 144-147 °C
Boiling Point: 828.2°C at 760 mmHg
InChIKey: UBORTCNDUKBEOP-UUOKFMHZSA-N
CanonicalSMILES: C1=NC2=C(N1C3C(C(C(O3)CO)O)O)NC(=O)NC2=O
IUPAC Name: 9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-purine-2,6-dione
InChI: InChI=1S/C10H12N4O6/c15-1-3-5(16)6(17)9(20-3)14-2-11-4-7(14)12-10(19)13-8(4)18/h2-3,5-6,9,15-17H,1H2,(H2,12,13,18,19)/t3-,5-,6-,9-/m1/s1
Synonyms: 1H-Purine-2,6-dione, 3,9-dihydro-9-β-D-ribofuranosyl-; 2,3-Dihydro-2-oxoinosine; 3,9-Dihydro-9-β-D-ribofuranosyl-1H-purine-2,6-dione; 9-β-D-Ribofuranosylxanthine; Inosine, 2,3-dihydro-2-oxo-; NSC 18930; β-D-Ribofuranoside, xanthine-9; Xanthine riboside
2-Thioadenosine
Description: 2-Thioadenosine is a modified nucleoside where the oxygen atom at the 2-position of the adenosine molecule is replaced with a sulfur atom. 2-Thioadenosine is an important modified nucleoside used in research to understand nucleic acid biochemistry and to develop potential therapeutic agents. Its unique sulfur substitution provides distinct properties that can be leveraged in various biological and medical applications. It is also an impurity of Cangrelor.
CAT: BRP-01906
CAS: 43157-50-2
MF: C10H13N5O4S
MF: 299.31
Purity: ≥95%
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | -- | -- |
Storage: Store at 2-8 °C, protect from light
Density: 2.18±0.1 g/cm3
Melting Point: >178 °C
Boiling Point: 544.5±60.0 °C at 760 mmHg
InChIKey: LTESOZAUMTUKQX-UUOKFMHZSA-N
CanonicalSMILES: C1=NC2=C(NC(=S)N=C2N1C3C(C(C(O3)CO)O)O)N
IUPAC Name: 6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purine-2-thione
InChI: InChI=1S/C10H13N5O4S/c11-7-4-8(14-10(20)13-7)15(2-12-4)9-6(18)5(17)3(1-16)19-9/h2-3,5-6,9,16-18H,1H2,(H3,11,13,14,20)/t3-,5-,6-,9-/m1/s1
Synonyms: 6-Amino-9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-3,9-dihydro-2H-purine-2-thione; Cangrelor Impurity 6; 2-Mercaptoadenosine; Adenosine, 1,2-dihydro-2-thioxo-; 2,3-Dihydro-2-thioxoadenosine; Adenosine, 2,3-dihydro-2-thioxo-
m-Topolin riboside
Description: m-Topolin riboside, an esteemed compound employed in the realm of biomedical research, unveils remarkable possibilities in combatting a myriad of ailments, ranging from cancer to neurological disorders. Its intricate composition and distinctive mode of operation engender a plethora of revitalizing attributes, particularly in terms of thwarting tumor progression and safeguarding neural integrity.
CAT: BRP-01907
CAS: 110505-76-5
MF: C17H19N5O5
MF: 373.36
Purity: ≥98% by HPLC
Appearance: White to off-white powder
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | -- | -- |
Storage: Store at 2-8 °C, protect from light
Density: 1.71±0.1 g/cm3
Melting Point: 195.6-196.5°C (water)
Boiling Point: 755.0±70.0 °C at 760 mmHg
InChIKey: CMTVBCOBYCGDJR-LSCFUAHRSA-N
CanonicalSMILES: C1=CC(=CC(=C1)O)CNC2=C3C(=NC=N2)N(C=N3)C4C(C(C(O4)CO)O)O
IUPAC Name: (2R,3S,4R,5R)-2-(hydroxymethyl)-5-[6-[(3-hydroxyphenyl)methylamino]purin-9-yl]oxolane-3,4-diol
InChI: InChI=1S/C17H19N5O5/c23-6-11-13(25)14(26)17(27-11)22-8-21-12-15(19-7-20-16(12)22)18-5-9-2-1-3-10(24)4-9/h1-4,7-8,11,13-14,17,23-26H,5-6H2,(H,18,19,20)/t11-,13-,14-,17-/m1/s1
Synonyms: (2R,3R,4S,5R)-2-(6-((3-Hydroxybenzyl)amino)-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; N6-(3-Hydroxybenzyl)adenosine; 6-(3-Hydroxybenzylamino)-9-b-D-ribofuranosylpurine; Adenosine, N-[(3-hydroxyphenyl)methyl]-; N-(3-Hydroxybenzyl)adenosine; N-[(3-Hydroxyphenyl)methyl]adenosine; Meta-topolin riboside; Meta-topolin-9-riboside; N6-(m-Hydroxybenzyl)adenosine
2-Chloroadenosine hemihydrate
Description: 2-Chloroadenosine hemihydrate is a versatile nucleoside analog used in various pharmacological and biochemical studies. Its role as an adenosine receptor agonist makes it valuable for research into adenosine signaling, potential therapeutic applications in cardioprotection, anticancer activity, and anti-inflammatory effects.
CAT: BRP-01908
CAS: 81012-94-4
MF: C10H12ClN5O4.1/2H2O
MF: 621.39
Purity: 98%
Appearance: Solid powder
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | -- | -- |
Storage: Store at 2-8 °C
Melting Point: 160 °C (dec.)
Boiling Point: 717.2 °C at 760 mmHg
InChIKey: WRURCFOLSGPTMO-IZGCVNAISA-N
CanonicalSMILES: C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)Cl)N.C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)Cl)N.O
IUPAC Name: (2R,3R,4S,5R)-2-(6-amino-2-chloropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol;hydrate
InChI: InChI=1S/2C10H12ClN5O4.H2O/c2*11-10-14-7(12)4-8(15-10)16(2-13-4)9-6(19)5(18)3(1-17)20-9;/h2*2-3,5-6,9,17-19H,1H2,(H2,12,14,15);1H2/t2*3-,5-,6-,9-;/m11./s1
Synonyms: Adenosine, 2-chloro-, hydrate (2:1); (2R,3R,4S,5R)-2-(6-amino-2-chloro-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol hemihydrate; 2-Chloro-D-adenosine hemihydrate; Antibiotic AT 265B hemihydrate; CADO hemihydrate
Related CAS: 146-77-0 (anhydrous)
4-Amino-1-(6-(hydroxymethyl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)-1,3,5-triazin-2(1H)-one
Description: 4-Amino-1-(6-(hydroxymethyl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)-1,3,5-triazin-2(1H)-one is an intriguing organic compound that has been extensively researched in the biomedical industry. The compound displays remarkable potential as a DNA topoisomerase inhibitor, a crucial enzyme involved in DNA replication and cell growth. Its distinctive chemical structure is expected to revolutionize drug discovery and development for the treatment of various cancers and microbial infections.
CAT: BRP-01909
CAS: 686300-58-3
MF: C11H16N4O5
MF: 284.27
Purity: 98%
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | -- | -- |
Storage: Store at 2-8°C
Density: 1.78±0.1 g/cm3
Boiling Point: 454.4±55.0 °C at 760 mmHg
InChIKey: JPOUCJFPOOJFME-UHFFFAOYSA-N
CanonicalSMILES: CC1(OC2C(OC(C2O1)N3C=NC(=NC3=O)N)CO)C
IUPAC Name: 4-amino-1-[6-(hydroxymethyl)-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-4-yl]-1,3,5-triazin-2-one
InChI: InChI=1S/C11H16N4O5/c1-11(2)19-6-5(3-16)18-8(7(6)20-11)15-4-13-9(12)14-10(15)17/h4-8,16H,3H2,1-2H3,(H2,12,14,17)
Synonyms: 4-amino-1-[2,3-O-(1-methylethylene)pentofuranosyl]-1,3,5-triazine-2(1H)-one
Related CAS: 65370-90-3 (4-Amino-1-[2,3-O-(1-methylethylidene)-β-D-ribofuranosyl]-1,3,5-triazin-2(1H)-one)
(3aS,4S,6R,6aR)-6-(6-chloro-purin-9-yl)-2,2-dimethyl-tetrahydro-furo[3,4-d][1,3]dioxole-4-carboxylic acid
Description: (3aS,4S,6R,6aR)-6-(6-chloro-purin-9-yl)-2,2-dimethyl-tetrahydro-furo[3,4-d][1,3]dioxole-4-carboxylic acid is a specialized structural analogue of the purine family. It plays an important role in gene response research, and foreseeable areas of application include manufactured oncology therapeutics.
CAT: BRP-01910
CAS: 120355-42-2
MF: C13H13ClN4O5
MF: 340.72
Purity: 98%
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | -- | -- |
Storage: Store at -20 °C, sealed storage, away from moisture
Density: 1.89±0.1 g/cm3
Boiling Point: 582.2±60.0 °C at 760 mmHg
InChIKey: BWQOSYSWEARUOW-MCHASIABSA-N
CanonicalSMILES: CC1(OC2C(O1)C(OC2C(=O)O)N3C=NC4=C3N=CN=C4Cl)C
IUPAC Name: (3aR,4R,6S,6aS)-4-(6-chloropurin-9-yl)-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxole-6-carboxylic acid
InChI: InChI=1S/C13H13ClN4O5/c1-13(2)22-6-7(23-13)11(21-8(6)12(19)20)18-4-17-5-9(14)15-3-16-10(5)18/h3-4,6-8,11H,1-2H3,(H,19,20)/t6-,7+,8-,11+/m0/s1
Synonyms: β-D-Ribofuranuronic acid, 1-(6-chloro-9H-purin-9-yl)-1-deoxy-2,3-O-(1-methylethylidene)-; 1-(6-Chloro-9H-purin-9-yl)-1-deoxy-2,3-O-(1-methylethylidene)-β-D-ribofuranuronic acid
8-Bromo-5'-O-[(4-cyanophenyl)methyl]-2',3'-di-O-(1-methylethylidene)adenosine
Description: 8-Bromo-5'-O-[(4-cyanophenyl)methyl]-2',3'-di-O-(1-methylethylidene)adenosine is a remarkable pharmaceutical compound with anti-inflammatory and immunomodulatory attributes. Potential applications include the research of various inflammatory ailments like rheumatoid arthritand asthma.
CAT: BRP-01911
CAS: 1134156-53-8
MF: C21H21BrN6O4
MF: 501.33
Purity: ≥95%
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | -- | -- |
Storage: Store at 2-8 °C
Density: 1.73±0.1 g/cm3
Boiling Point: 712.8±70.0°C at 760 mmHg
InChIKey: XSPCSNCZRVWYLT-NVQRDWNXSA-N
CanonicalSMILES: CC1(OC2C(OC(C2O1)N3C4=NC=NC(=C4N=C3Br)N)COCC5=CC=C(C=C5)C#N)C
IUPAC Name: 4-[[(3aR,4R,6R,6aR)-4-(6-amino-8-bromopurin-9-yl)-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]methoxymethyl]benzonitrile
InChI: InChI=1S/C21H21BrN6O4/c1-21(2)31-15-13(9-29-8-12-5-3-11(7-23)4-6-12)30-19(16(15)32-21)28-18-14(27-20(28)22)17(24)25-10-26-18/h3-6,10,13,15-16,19H,8-9H2,1-2H3,(H2,24,25,26)/t13-,15-,16-,19-/m1/s1
Synonyms: 8-Bromo-5'-O-(4-cyanobenzyl)-2',3'-di-O-isopropylidene adenosine; 4-[[(3aR,4R,6R,6aR)-4-(6-amino-8-bromopurin-9-yl)-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]methoxymethyl]benzonitrile; Adenosine, 8-bromo-5'-O-[(4-cyanophenyl)methyl]-2',3'-O-(1-methylethylidene)-; 8-Bromo-5'-O-[(4-cyanophenyl)methyl]-2',3'-O-(1-methylethylidene)adenosine; 4-((((3AR,4R,6R,6aR)-6-(6-amino-8-bromo-9H-purin-9-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methoxy)methyl)benzonitrile
((3aR,4R,6R,6aR)-6-(6-amino-9H-purin-9-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl sulfamate
Description: (3aR,4R,6R,6aR)-6-(6-amino-9H-purin-9-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl sulfamate is a complex bio-chemical compound finding prevalent utilization tactically within the spheres of pharmaceutical expeditions. Particularly exploited for antiviral drug architecture, it can combat ailments birthed by the malicious herpes simplex and varicella-zoster viruses.
CAT: BRP-01912
CAS: 112921-00-3
MF: C13H18N6O6S
MF: 386.38
Purity: 95%
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | -- | -- |
Storage: Store at -20°C
Density: 1.96±0.1 g/cm3(Predicted)
Melting Point: 194-196 °C
Boiling Point: 663.8±65.0 °C at 760 mmHg
InChIKey: PCKRSJUZRCXCIR-UHFFFAOYSA-N
CanonicalSMILES: CC1(OC2C(OC(C2O1)N3C=NC4=C(N=CN=C43)N)COS(=O)(=O)N)C
IUPAC Name: [4-(6-aminopurin-9-yl)-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]methyl sulfamate
InChI: InChI=1S/C13H18N6O6S/c1-13(2)24-8-6(3-22-26(15,20)21)23-12(9(8)25-13)19-5-18-7-10(14)16-4-17-11(7)19/h4-6,8-9,12H,3H2,1-2H3,(H2,14,16,17)(H2,15,20,21)
Synonyms: Adenosine, 2',3'-O-(1-methylethylidene)-, 5'-sulfamate; 2',3'-O-(1-Methylethylidene)adenosine, 5'-sulfamate
2-Acetamido-6-chloro-9-(2',3',5'-tri-O-acetyl-β-D-ribofuranosyl)purine
Description: 2-Acetamido-6-chloro-9-(2',3',5'-tri-O-acetyl-β-D-ribofuranosyl)purine is a remarkable antiviral compound, showing potential in combating a range of viral infections. By impeding viral replication and augmenting immune responses, this compound manifests as a promising tool against afflictions caused by herpes simplex virus and human immunodeficiency virus (HIV).
CAT: BRP-01913
CAS: 137896-02-7
MF: C18H20ClN5O8
MF: 469.83
Purity: 95%
Appearance: Light Orange Solid
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | -- | -- |
Storage: Store at -20°C
Density: 1.63±0.1 g/cm3 (Predicted)
Melting Point: 71-73 °C
InChIKey: OVXYEIBYTBNNFE-LSCFUAHRSA-N
Solubility: Soluble in Acetone, Chloroform, Methanol
CanonicalSMILES: CC(=O)NC1=NC2=C(C(=N1)Cl)N=CN2C3C(C(C(O3)COC(=O)C)OC(=O)C)OC(=O)C
IUPAC Name: [(2R,3R,4R,5R)-5-(2-acetamido-6-chloropurin-9-yl)-3,4-diacetyloxyoxolan-2-yl]methyl acetate
InChI: InChI=1S/C18H20ClN5O8/c1-7(25)21-18-22-15(19)12-16(23-18)24(6-20-12)17-14(31-10(4)28)13(30-9(3)27)11(32-17)5-29-8(2)26/h6,11,13-14,17H,5H2,1-4H3,(H,21,22,23,25)/t11-,13-,14-,17-/m1/s1
Synonyms: N-[6-Chloro-9-(2',3',5'-tri-O-acetyl-β-D-ribofuranosyl)-9H-purin-2-yl]acetamide; (2R,3R,4R,5R)-2-(2-acetamido-6-chloro-9H-purin-9-yl)-5-(acetoxymethyl)tetrahydrofuran-3,4-diyl diacetate
5'-Amino-5'-deoxy-2',3'-O-(1-methylethylidene)-adenosine
Description: 5'-Amino-5'-deoxy-2',3'-O-(1-methylethylidene)-adenosine, an exceptionally potent nucleoside analogue, exhibits remarkable antiviral characteristics. Its application in the biomedical sector revolves around combatting viral infections, primarily those necessitating adenosine for replication. An impressive attribute of this substance lies in its ability to impede viral replication by derailing the intricate viral RNA synthesis pathway, rendering it highly efficacious against an extensive spectrum of viral ailments.
CAT: BRP-01914
CAS: 21950-36-7
MF: C13H18N6O3
MF: 306.32
Purity: 98%
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | -- | -- |
Storage: Store at 2-8 °C, protect from light
Density: 1.80±0.1 g/cm3
Melting Point: 202-203 °C
Boiling Point: 553.1±60.0 °C at 760 mmHg
InChIKey: RGJLVQRLOVOJRF-WOUKDFQISA-N
CanonicalSMILES: CC1(OC2C(OC(C2O1)N3C=NC4=C(N=CN=C43)N)CN)C
IUPAC Name: 9-[(3aR,4R,6R,6aR)-6-(aminomethyl)-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-4-yl]purin-6-amine
InChI: InChI=1S/C13H18N6O3/c1-13(2)21-8-6(3-14)20-12(9(8)22-13)19-5-18-7-10(15)16-4-17-11(7)19/h4-6,8-9,12H,3,14H2,1-2H3,(H2,15,16,17)/t6-,8-,9-,12-/m1/s1
Synonyms: 9-[(3aR,4R,6R,6aR)-6-(aminomethyl)-2,2-dimethyl-tetrahydro-2H-furo[3,4-d][1,3]dioxol-4-yl]-9H-purin-6-amine; Adenosine, 5'-amino-5'-deoxy-2',3'-O-(1-methylethylidene)-; 5'-Amino-5'-deoxy-2',3'-O-isopropylidineadenosine
6-Aza-2-thiouridine
Description: 6-Aza-2-thiouridine is a remarkable compound with profound antiviral effects, exhibiting exceptional inhibitory potency against a myriad of RNA viruses encompassing Influenza A and the notorious Zika virus. Its formidable prowess resides in its unrivaled disruption of viral RNA research and development, unequivocally dismantling the intricate replication machinery.
CAT: BRP-01915
CAS: 27089-56-1
MF: C8H11N3O5S
MF: 261.26
Purity: 98%
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | -- | -- |
Storage: Store at 2-8 °C, stored under nitrogen
Density: 2.02±0.1 g/cm3
Melting Point: 201-203 °C
InChIKey: TVCBDTCUOVDLNZ-SHUUEZRQSA-N
CanonicalSMILES: C1=NN(C(=S)NC1=O)C2C(C(C(O2)CO)O)O
IUPAC Name: 2-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3-sulfanylidene-1,2,4-triazin-5-one
InChI: InChI=1S/C8H11N3O5S/c12-2-3-5(14)6(15)7(16-3)11-8(17)10-4(13)1-9-11/h1,3,5-7,12,14-15H,2H2,(H,10,13,17)/t3-,5-,6-,7-/m1/s1
Synonyms: 2-Thio-6-azauridine; 3,4-Dihydro-2-β-D-ribofuranosyl-3-thioxo-1,2,4-triazin-5(2H)-one; as-Triazine-3,5(2H,4H)-dione, 2-β-D-ribofuranosyl-3-thio-; 1-β-D-Ribofuranosyl-2-thio-6-azauracil
2-O-Methyl-5-methyluridine
Description: 2-O-Methyl-5-methyluridine is an indispensable compound with potential antiviral and anticancer activities.
CAT: BRP-01916
CAS: 114952-97-5
MF: C11H16N2O6
MF: 272.25
Purity: ≥95%
Appearance: White to off-white powder
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | -- | -- |
Density: 1.61±0.1 g/cm3
Boiling Point: 485.4±55.0°C at 760 mmHg
InChIKey: LTVSTRRNQLBTBJ-FDDDBJFASA-N
CanonicalSMILES: CC1=CN(C(=NC1=O)OC)C2C(C(C(O2)CO)O)O
IUPAC Name: 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-methoxy-5-methylpyrimidin-4-one
InChI: InChI=1S/C11H16N2O6/c1-5-3-13(11(18-2)12-9(5)17)10-8(16)7(15)6(4-14)19-10/h3,6-8,10,14-16H,4H2,1-2H3/t6-,7-,8-,10-/m1/s1
Synonyms: Uridine, 5-methyl-2-O-methyl-; 5-Methyl-2-O-methyl-uridine; 2-Methoxy-5-methyl-1-(β-D-ribofuranosyl)-4(1H)-pyrimidinone; 4(1H)-Pyrimidinone, 2-methoxy-5-methyl-1-β-D-ribofuranosyl-; 1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-methoxy-5-methylpyrimidin-4(1H)-one
Related CAS: 55486-09-4 (5-Methyl-2'-O-methyluridine)
